Consortia
Memberships
Plan S
ASAP is a proud member of Plan S, an initiative for Open Access publishing. The plan is supported by cOAlition S, an international consortium of research funding and performing organizations. Plan S requires that, from 2021, scientific publications that result from research funded by public grants must be published in compliant Open Access journals or platforms.
Open Research Funders Group
ASAP is proud to join alongside philanthropic organizations as a member of The Open Research Funders Group (ORFG). ORFG is a partnership of funding organizations committed to the open sharing of research outputs and other forms of scholarship. The ORFG has two primary programmatic pillars: (1) engaging philanthropies in a community of practice to develop, implement, oversee, and advance strategies that accelerate access to funded research, including papers and data; and (2) serving as the funders’ voice in cross-sector discussions about open research policies, incentives, infrastructure, and good practices.
AMP® PDRD
The Accelerating Medicine Partnership in Parkinson’s Disease and Related Disorders (AMP® PDRD) is a public-private partnership between the National Institutes of Health (NIH), multiple biopharmaceutical and life science companies, and nonprofit organizations. Managed through the Foundation for the NIH (FNIH), AMP® PDRD aims to harmonize Parkinson’s and related disease datasets across the community with the goal of identifying and validating diagnostic, prognostic, and/or progression biomarkers for Parkinson’s disease, with an emphasis on broadening data sharing in the biomedical community to advance Parkinson’s research. ASAP is proud to be a partner in the AMP® PDRD effort to broaden data sharing in the biomedical community to advance Parkinson’s research. Both GP2 and PPMI cohorts share their data on this platform.
News & Updates
Our initiative is accelerating the pace of discovery for Parkinson’s disease through collaboration, research-enabling resources, and data sharing.
Gut Microbiome Can Reveal Risk of Parkinson’s, Scientists Say
May 5, 2026
The Guardian reports on a breakthrough study by CRN Team Schapira, which identified a distinct gut microbial "signature" that can signal Parkinson's risk years before physical symptoms appear.
Learn More
Aligning Science Across Parkinson’s and The Michael J. Fox Foundation Expand Global Research Initiative with $261M Investment Toward Personalized Treatments
April 28, 2026
ASAP and MJFF announced $261 million in new grant funding for the Collaborative Research Network (CRN) to map the biological blueprint of Parkinson’s disease and build a standardized toolkit of global research resources that are needed to turn discoveries into treatments.
Learn More
Inaugural Cohort of Discovery Fellows Aim to Become the Next Generation of Parkinson’s Researchers
April 20, 2026
ASAP is proud to showcase the inaugural cohort of Discovery Fellows. Learn more about the funded projects!
Learn More